Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in ...

Wes Streeting has announced a new strategy to cut down on the number of single-use medical devices used by the NHS.

Johnson & Johnson has been a stalwart dividend stock over the years because it has maintained a healthy financial profile, ...

If the scheduled execution moves forward, it will be Idaho’s fifth such effort since capital punishment resumed in 1976.

Scientists have grown arteries using human cells to better treat injured patients. They’ve already been effective in ...

The healthcare delivered in high-income countries is riddled with defects in value. One in 10 patients experiences harm when ...